Search PubMed⌕ Search

Biomedical subjects

H Haindl

Publications and source records attributed to H Haindl.

34 records · Page 2Linked to original sources
PubMed1979

The influence of chemotherapy on the distribution of 57Co-bleomycin in chemically induced squamous cell carcinoma of mouse skin.

Organ distribution and tumor uptake of 57Co-bleomycin (BLM) were examined in NMRI mice without tumor and with chemically (DMBA-) induced squamous cell carcinoma. In these tumors high accumulation of 57Co-BLM was recorded shortly after injection of 57Co-BLM and low uptake 24--48 h after application. Two groups of tumor-bearing mice received unlabeled bleomycin as a cytostatic in two different doses. Uptake of 57Co-bleomycin was reduced. The study suggests that in patients currently or previously under chemotherapy, 57Co-bleomycin tumor scintigraphy may lead to false negative results.

Animals↗
PubMed1979

Evaluation of enzyme immunoassays for determination of thyroxine (EMIT, ENZYMUN) and of thyroxine binding index.

An evaluation of enzyme immunoassays for determination of thyroxine in serum (EMIT ABA thyroxine assay, Syva Corp., ENZYMUN assay thyroxine, Boehringer Mannheim) and of thyroxine binding index (ENZYMUN assay TBI1), Boehringer Mannheim) is presented. The precision of the enzyme immunoassays was adequate (coefficients of variation ranged from day to day with EMIT from 3--11% and with ENZYMUN from 4--11%). Both assays are specific and easy to perform. About 20 unknown samples can be analyzed in duplicate by EMIT within 60 minutes and by ENZYMUN within 250 minutes. A comparison of the results obtained by enzyme immunoassays and radioimmunoassay in a series of about 100 patients showed a good correlation between both methods. The precision of the ENZYMUN TBI assay was adequate (coefficient of variation from day to day 4.9%) and the thyroxine/TBI-ratio correlated well with the thyroxine/TBG-ratio.

Humans↗
PubMed1979

[Influence of radiotherapy upon tumor accumulation and organ distribution of 57Co-bleomycin in mice with chemically induced squamous cell carcinoma (author's transl)].

Squamous cell carcinoma was induced in male 6 to 8-week old NMRI-mice by application of 9,10-dimethyl-1,2-benzanthracene on the skin. 15 weeks later macroscopically visible skin tumors are developed. Then organ distribution and tumor accumulation of 57Co-Bleomycin (spec. activity 1 mCi/3.3 mg) were studied 1 to 48 hours after injection. In squamous cell carcinoma a high uptake of this tumor-seeking agent can be demonstrated (n = 46). After radiotherapy (100 kV; 1.7 mm Al-filter; 18.8 Gy) (n = 26), however, a significantly reduced uptake of 57Co-Bleomycin in tumor tissue is observed. Possible consequences from these animal studies for tumor scintigraphy with this radiopharmaceutical in man are discussed.

9,10-Dimethyl-1,2-benzanthracene↗
PubMed1977

[Hormone replacement in patients with carcinoma of the thyroid (author's transl)].

82 patients with well-differentiated thyroid carcinoma had been treated by total thyroidectomy and radioiodine destruction of any residual thyroid tissue. They were then given high doses of L-thyroxine (T4), enough to suppress endogenous stimulation by TSH, the recommended dose being at least 300 microgram daily. Six weeks after starting 150 microgram T4 daily there was no significant response to 400 microgram TRH i.v. in 56% of the 82 patients. The T4 dose was then increased until all TRH tests had become negative. There was a significant correlation between the number of negative tests and body surface: at a dose of 40-60 microgram/m2 none of the tests was negative, while at a dose of 80-100 microgram/m2 the test was negative in 83%, the frequency of negative tests increasing up to 94% at higher doses. Mild hyperthyroidism occurred in 17%. It is concluded that after adequate surgical and radioiodine treatment 80-100 microgram/m2 T4 should be given to patients with well-differentiated thyroid carcinoma. The effectiveness of suppressing TSH levels should be checked with the TRH test after six weeks.

Humans↗
PubMed1977

[Relationship between digoxin-induced cardiac arrhythmias and serum-digoxin levels (author's transl)].

The serum-digoxin level was measured by radio-immunoassay (Immutope) on 245 patients in a coronary care unit. Cardiac arrhythmias were assumed to be digoxin-induced if they disappeared after the drug had been stopped. Patients who had received digitoxin or spironolactone were excluded. The results indicated a normal digoxin range of 1.52 +/- 0.2 ng/ml and a toxic one of 2.78 +/- 0.38 ng/ml. First degree A-V block, atrial ectopic beats and ventricular ectopics with variable coupling intervals were frequently associated with serum-digoxin levels of 1.5-2.5 ng/ml, while higher grade A-V block, atrial tachycardia, bigeminy and atrial tachycardia with block were more frequent with higher serum-digoxin levels (greater than 3.0 ng/ml). Atrial arrhythmias were especially frequent with serum levels above 3.0 ng/ml. This suggests different sensitivities of atrial and ventricular myocardium. Atrial arrhythmias thus in general indicate a higher degree of toxicity at high serum levels, while ventricular ectopic beats occur both with high serum levels and also with increased digoxin sensitivity of the ventricles.

Arrhythmias, Cardiac↗
PubMed1976

[The effect of contrast media containing iodine on selected in vitro thyroid test procedures (author's transl)].

The effect of 6 commonly used contrast media on the results of 3 different methods for determination of thyroid hormone concentration in the serum is examined in vivo. T4 determination by column chromatography proved to be very liable to distortion for contrast media. With some contrast media the Res-O-Mat-ETR test proved unreliable. T4 determination by means of protein binding analysis is not affected by contrast media in the direction of false raised values.

Adult↗
PubMed1976

[Intraerythrocytic enzyme activities in euthyroid subjects and hyperthyroid patients before treatment and following stabilization of metabolism using radioiodine therapy].

The activities of six intra-erythrocytic enzymes--glucose-6-phosphate-dehydrogenase, aldolase, pyruvate kinase, hexokinase, triosephosphate-isomerase and phosphoglucomutase--have been measured in euthyroid probands (n=18) and in hyperthyroid patients (n=13) prior to radioiodine therapy and after stabilization of the metabolic conditions. The hexokinase, triosephosphate-isomerase, pyruvate kinase, and glucose-6-phosphate-dehydrogenase did not show any significant changes. A moderate diminution of the aldolase activity and a distinct decrease of the phosphoglucomutase activity occur during hyperthyroidism. After normalization of the metabolic conditions, both the enzymatic activities increase again.

Erythrocytes↗
PubMed1975

Comparison of four different methods for the recovery of dotriacontane-16,17-14C from small animal respiratory tissue.

The efficiency and accuracy of four different methods of tissue preparation for the recovery of dotriacontane-16,17-14C (DOT-16,17-14C) from rat respiratory tissue were compared by means of liquid scintillation counting. A DOT-16,17-14C standard solution was placed on the respiratory epithelium of the nasal apex, larynx, trachea and main bronchi. Combustion of the lyophilized organs in a Packard sample oxidizer revealed the highest recovery and accuracy (93--100%), sample oxidizing by combustion without lyophilization the lowest recovery and accuracy (73--92%). Tissue solubilization by the commercially available tissue solubilizer TS-1 revealed a better recovery and accuracy (89--95%) than tissue maceration by boiling in methanolic KOH and toluene extraction (74--91%). Depending on the laboratory equipment, lyophilization or tissue solubilization is preferred; maceration and toluene extraction as well as combustion without freeze-drying are disregarded for further investigations because of the cumbersome procedure as well as the low recovery and accuracy, respectively.

Animals↗
PubMedDate not supplied

Safety of medical disposables.

Because of the heterogeneous nature of medical disposables, it is hard to define a uniform safety standard that is applicable to all products. Although good manufacturing practice (GMP) standards outline the framework for manufacturing conditions, a coherent safety philosophy for medical disposables does not exist. This article defines safety as it applies to these products and describes the various factors that can affect product safety, including economy, design, and inadequate instructions for use.

Consumer Product Safety↗
PubMedDate not supplied

[Life expectancy indicator for re-sterilizable plastic materials].

Semi-disposable products in which only part of the product is disposable while another part made of plastic is designed to be reusable, are an effective counter to the increasing masses of plastic waste generated by hospitals. The major problem with such products has been the fact that the resterilizable parts could withstand only a limited number of resterilizations and the user had no means of seeing when this number had been reached. To resolve this problem, the Life-Span Indicator was developed in cooperation with Beiersdorf AG. This indicator changes colour from blue to orange after about 100 sterilizations. It is based on an azo pigment diffused into a carrier polymer, POM. Repeated heating of the slow colour change of the pigment. Not all the details of the mechanisms involved are clear, but the indicator functions reliably and reproducibly. Since the pigment is inside the polymer, the colour-change reaction is not affected by mechanical pre-cleaning or disinfection. The user can thus readily see how long he can use such products without risking malfunction. The number of resterilizations can be varied to suit the product, and the indicator can be shaped as required, for example as a nonseparable snap-in plug or a capable binder.

Color↗